Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified Health Condition 2: C069- Malignant neoplasm of mouth, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients suffering from Oral Squamous Cell Carcinoma Patients suffering from Oesophageal Squamous Cell Carcinoma Patients who have not yet undergone any Surgical therapy/ Chemotherapy/ Radiotherapy for treatment of the carcinoma Patients willing to give informed consent Patients with minimum 20 teeth
Exclusion criteria
Exclusion criteria: Patients with any malignancy other than squamous cell carcinoma of the oral cavity/ esophagus Patients undergoing any treatment for carcinoma or its recurrence History of antibiotic use in the previous three months Pregnant or lactating females Patients who received periodontal treatment within the last 6 months Patients who require antibiotic prophylaxis before examination Patients unwilling to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arbitrarily primed polymerase chain reaction (AP-PCR) fingerprinting of P. gingivalis isolates from dental plaque, saliva, healthy and tumour tissue in patients with Oral/ Oesophageal cancersTimepoint: baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of P. gingivalis strain with periodontal health statusTimepoint: baseline;Correlation of the prevalence rate of P.gingivalis in saliva with that in dental plaque samples and tumour tissuesTimepoint: baseline;Estimation of prevalence rate of P. gingivalis in healthy and tumour tissue of patients with Oral/ Oesophageal cancers using MALDI-TOF MS.Timepoint: baseline;Estimation of prevalence rate of P. gingivalis in saliva & dental plaque of patients with Oral/ Oesophageal cancers using MALDI-TOF MSTimepoint: baseline;To estimate the prevalence of Periodontal disease in patients suffering from Oral/ Oesophageal cancers by recording the Periodontal status of all subjects Timepoint: BASELINE | — |
Countries
India
Contacts
ORAL HEALTH SCIENCES CENTRE, SECTOR 12, PGIMER